SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
28.22
+0.72 (2.62%)
At close: Feb 13, 2026, 4:00 PM EST
27.41
-0.81 (-2.87%)
After-hours: Feb 13, 2026, 5:03 PM EST
SpyGlass Pharma Market Cap
SpyGlass Pharma has a market cap or net worth of $940.22 million as of February 13, 2026.
Market Cap
940.22M
Enterprise Value
1.03B
1-Year Change
n/a
Ranking
Category
Stock Price
28.22
Market Cap Chart
Since the IPO on February 6, 2026, SpyGlass Pharma's market cap has increased from $510.58M to $940.22M, an increase of 84.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 940.22M | 2.62% |
| Feb 12, 2026 | 916.23M | -0.18% |
| Feb 11, 2026 | 917.89M | -1.01% |
| Feb 10, 2026 | 927.22M | 6.30% |
| Feb 9, 2026 | 872.25M | 70.84% |
| Feb 6, 2026 | 510.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 975.50M |
| Fortrea Holdings | 967.43M |
| Phathom Pharmaceuticals | 963.81M |
| ArriVent BioPharma | 958.55M |
| CytomX Therapeutics | 931.89M |
| GH Research | 931.06M |
| AbCellera Biologics | 930.93M |
| Aktis Oncology | 919.67M |